Company news
Minerva Neurosciences, Inc news in 2023
Minerva Neurosciences, Inc's news releases, calls and decks from 2023, newest first.
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
November 6, 2023
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
July 31, 2023
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
June 27, 2023
Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates
May 14, 2023
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
May 9, 2023
Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023
May 7, 2023
Minerva Neurosciences Announces the NDA Filing for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
April 30, 2023
Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
March 7, 2023
Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023
February 28, 2023